Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1-Reference-Cited by-同舟云学术

Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1

Published:2022-11 Issue: Volume:185 Page:106462
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Kanojia Deepika,Kirtonia Anuradha,Srujana Namburi Sai Valli,Jeevanandan Sree Priyanka,Shyamsunder Pavithra,Sampath Shruthi Sanjitha,Dakle Pushkar,Mayakonda Anand,Kaur Harvinder,Yanyi Jiang,Koeffler H.Phillip,Garg Manoj

Publisher

Elsevier BV

Subject

Pharmacology

Reference52 articles.

1. Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma;Crago;Curr. Opin. Oncol.,2011

2. Soft-tissue sarcomas;Vodanovich;Indian J. Orthop.,2018

3. A review of soft-tissue sarcomas: translation of biological advances into treatment measures;Hoang;Cancer Manag Res.,2018

4. Liposarcoma: multimodality management and future targeted therapies;Crago;Surg. Oncol. Clin. North Am.,2016

5. Metastatic soft tissue sarcomas: a review of treatment and new pharmacotherapies;Singhi;P T,2018

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. m6A modification of lncRNA ABHD11-AS1 promotes colorectal cancer progression and inhibits ferroptosis through TRIM21/IGF2BP2/ FOXM1 positive feedback loop;Cancer Letters;2024-08

2. Up-regulation of RAN by MYBL2 maintains osteosarcoma cancer stem-like cells population during heterogeneous tumor generation;Cancer Letters;2024-04

3. Dysregulation of different modes of programmed cell death by epigenetic modifications and their role in cancer;Cancer Letters;2024-03

4. Lnc-PSMA8-1 activated by GEFT promotes rhabdomyosarcoma progression via upregulation of mTOR expression by sponging miR-144-3p;BMC Cancer;2024-01-15

5. Genetic, Epigenetic and Transcriptome Alterations in Liposarcoma for Target Therapy Selection;Cancers;2024-01-08